How is phesgo administered
WebPhesgo will be administered subcutaneously (SC) at a fixed non-weight-based dose. In the induction therapy phase, a loading dose (1200 milligram (mg) pertuzumab, 600 mg trastuzumab, and 30,000 units of recombinant human PH20 hyaluronidase [rHuPH20]) will be administered in the first cycle (1 cycle is 21 days). Web10 jul. 2024 · Phesgo has been approved as a treatment for early and metastatic HER2-positive breast cancer. It's administered in the form of an injection that can be given …
How is phesgo administered
Did you know?
WebPhesgo should only be initiated under the supervision of a physician experienced in the administration of anti-cancer agents. Phesgo should be administered by a healthcare professional prepared to manage anaphylaxis and in an environment where full resuscitation facilities are immediately available (see section 4.4) . WebHow is Phesgo® given? Phesgo® is given by subcutaneous injection under the skin on your thigh. The administration of Phesgo® by subcutaneous injection will take between 5 …
Web23 jun. 2024 · Phesgo Injection, Subcutaneous Solution Pertuzumab is a humanized monoclonal antibody designed to bind to the HER2 receptor and inhibit the ability of … WebPhesgo’s RMP. I. THE MEDICINE AND WHAT IT IS USED FOR Phesgo is authorized for metastatic and early breast cancers (see SmPC for the full indication). It contains pertuzumab and trastuzumab as the active substance, and it is given by subcutaneous injection. Further information about the evaluation of Phesgo’s benefits can be found in …
WebWhen administered with PHESGO, the recommended initial dose of docetaxel is 75 mg/m 2 administered as an intravenous infusion. The dose may be escalated to 100 mg/m 2 …
Webensure that the drug being prepared and administered is Phesgo. Additionally, the fact that Phesgo should be administered via subcutaneous injection only is stated. Outer and …
WebAdministrarea de Phesgo trebuie întreruptă timp de cel puțin 3 săptămâni pentru o scădere a FEVS sub 50% asociată cu o scădere de ≥ 10% puncte sub valorile anterioare ale tratamentului. Administrarea de Phesgo poate fi reluată dacă FEVS a revenit la o valoare . ≥ 50% sau dacă există o simple math backgroundWebPhesgo is a fixed-dose combination of Perjeta (pertuzumab) and Herceptin (trastuzumab) with hyaluronidase, administered by subcutaneous (SC; under the skin) injection in combination with intravenous (IV) chemotherapy, for the treatment of early and metastatic HER2-positive breast cancer. simple math calculationsWebPHESGO should be administered every 3 weeks1 15 mL 10 mL The loading (initial) dose Maintenance doses • 1,200 mg pertuzumab, 600 mg trastuzumab, 30,000 units hyaluronidase per 15 mL supplied in a single-dose, ready-to-use vial • Administer subcutaneously over approximately 8 minutes at a rate of no more than 2 mL/min3 simple math conversionsWeb25 mrt. 2024 · For men: participants who agree to remain abstinent (refrain from heterosexual intercourse) or use a condom, and agree to refrain from donating sperm, during the treatment period and for 7 months after the final dose of Phesgo to avoid exposing the embryo Maintenance Phase Inclusion Criteria Complete a minimum of four … rawtherapee ubuntuWeb30 jun. 2024 · The drug, branded as Phesgo, is the first time South San Francisco-based Genentech has combined two monoclonal antibodies that can be administered by a single injection just under the skin in... simple math concepts for 6th grade mathWeb27 jan. 2024 · Phesgo is initially used in combination with chemotherapy. Phesgo can be administered subcutaneously into the thigh by a health professional at home once the … raw therapee stop image editingWebThere is a pregnancy pharmacovigilance program for PHESGO. If PHESGO is administered during pregnancy, or if a patient becomes pregnant while receiving PHESGO or within 7 months following the last dose of PHESGO, health care providers and patients should immediately report PHESGO exposure to Genentech at 1-888-835-2555. simple math concepts